Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need

By LabMedica International staff writers
Posted on 07 Sep 2022

When the requirement is for infectious disease testing, every minute counts to inform treatment decisions and slow the risk of transmission. More...

Having rapid multiplex PCR testing at the point of need can make life better for millions of people in hospitals, clinics, airports, care homes, events, workplaces, and a wider variety of other settings. Now, a portable and simple to use rapid multiplex PCR testing system delivers fast, accurate and actionable results in approximately 30 minutes at the point of need.

The Q-POC platform from QuantuMDx Group Ltd. (Tyne and Wear, UK) compresses an entire molecular diagnosis laboratory into a simple-to-use, accessible and portable single device that produces results in approximately 30 minutes. The many innovative features incorporated into the Q-POC platform make it a safe rapid multiplex PCR testing solution for all clinical environments. With the Q-POC supercharged platform, it is no longer necessary to wait hours or days for test results.

The Q-POCT platform has been engineered to limit the need for highly skilled operators and offer a smooth user experience behind each interaction with its intuitive interface. The software is designed with the simplicity and familiarity of smartphone and tablet interfaces. It requires only three minutes hands-on-time to get each test started, using easy to follow, guided workflows on the touch screen. A ready to use solution, with all its simplicity, accuracy and speed, the Q-POCT requires no calibration or preventive maintenance. Each test cassette contains all the necessary reagents to complete a test and can be stored and shipped at room temperature. Users can just load the cassette and press go.

A ton of tech is behind every result, with intelligent multilingual software algorithms integrated into the Q-POCT platform. Clear, simple test results are automatically generated by sophisticated software algorithms, removing any complicated interpretation of the result. The Q-POCT software has been designed with the user in mind and uses intuitive, user centric software design similar to a smartphone allowing clear and easy reporting. The small, portable, battery-operated Q-POCT system marks a huge leap in rapid multiplex PCR testing. Its compact design, as well as its internal lithium-ion battery, supports use in a wide variety of clinical settings, at the Point of Need.

Related Links:
QuantuMDx Group Ltd. 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automated Urinalysis Solution
UN-9000
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.